RxDoctor Payments Data

Leslie Fletcher

Primary Care · Torrance, CANPI 1033746359

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,488,647 of the $1,843,153 with a category attached, or 80.8%. AbbVie accounts for 100.0% of it on its own, with 3 other manufacturers making up the rest. Among primary care clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,843,153in general payments, 2019–2025

Across 2,507 payments — averaging $735.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1.8M
  • Galderma Laboratories, L.p.$490
  • Revance Therapeutics, Inc.$161
  • Bayer$43

What the payments were for

  • Consulting fees$128,9617%
  • Speaking & faculty fees$1,488,64781%
  • Travel & lodging$174,9749%
  • Food & beverage$49,5893%
  • Education$9830%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)2,495$1,842,458
Galderma Laboratories, L.p.8$490
Revance Therapeutics, Inc.2$161
Bayer2$43

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,843,153 in reported general payments places this provider in the 95th percentile of 706 primary care providers in California.

See all primary care providers in California

Other primary care in Torrance

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →